Evaluation of Traditional Chinese Medicinal Plants for Anti-MRSA Activity with Reference to the Treatment Record of Infectious Diseases by Zhong-Qi Bian et al.
Molecules 2012, 17, 2955-2967; doi: 10.3390/molecules17032955 
 
molecules 
ISSN 1420-3049 
www.mdpi.com/journal/molecules 
Article 
Evaluation of Traditional Chinese Medicinal Plants for 
Anti-MRSA Activity with Reference to the Treatment  
Record of Infectious Diseases 
Guo-Ying Zuo 
1,*, Xin-Juan Zhang 
1,2,†, Cui-Xian Yang 
1,3,†, Jun Han 
3, Gen-Chun Wang 
1 and 
Zhong-Qi Bian 
4,* 
1  Research Center for Natural Medicines, Kunming General Hospital, PLA, Kunming 650032, China; 
E-Mails: shmily_zxj2008@163.com (X.-J.Z.); ycx484@126.com (C.-X.Y.);  
kmwgc12@126.com (G.-C.W.) 
2  Kunming Medical College, Kunming 650032, China 
3  Yunnan Traditional Chinese Medical College, Kunming 650500, China; E-Mail: hanzjn@126.com 
4  Center for Infectious Diseases, Kunming General Hospital, PLA, Kunming 650032, China 
†  These authors contributed equally to this work. 
*  Authors to whom correspondence should be addressed; E-Mails: zuoguoying@263.net (G.-Y.Z.); 
bzq@ynu.edu.cn (Z.-Q.B.); Tel./Fax: +86-871-477-4941 (G.-Y.Z.). 
Received: 8 February 2012; in revised form: 27 February 2012 / Accepted: 29 February 2012 / 
Published: 9 March 2012 
 
Abstract: The in vitro antimicrobial activities of 30 Chinese medicinal plants were 
evaluated with reference to the treatment record of infectious diseases in the Traditional 
Chinese Medicine (TCM) literature. The plant materials were extracted with 80% ethanol 
and the extracts were primarily screened against conventional clinical pathogens like 
Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans 
by the agar diffusion method. Their inhibition zone diameters (IZDs, mm, 50 mg/mL) 
ranged from <8 to 24. The 21 extracts which showed IZDs ≥10 mm against MSSA were 
also active against methicillin-resistant S. aureus (MRSA) with lower IZDs of 9.0–18.8 mm. 
They were further subjected to minimal inhibitory concentration and minimal bactericidal 
concentration (MIC/MBC, μG/mL) assays, which were 8-2,048/32->2,048 by the standard 
broth microdilution method. The seven extracts from M. yunnanensis, S. sinensis, G. morella, 
E. daneillii, M. squamulata, S. arborescens and B. hancei were determined as the most 
active extracts, with MICs of 8–64 μg/mL. The results were in good agreement with their 
traditional applications in skin and other infections. 
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1. Introduction 
Staphylococcus aureus infections range from common skin infections, such as furunculosis and 
impetigo, to severe deep-seated infections. S. aureus ranks first or second among bacterial pathogens 
causing bloodstream infections. It is the leading cause of nosocomial pneumonia and it also causes 
infections of surgical wounds and prosthetic implants. Clinical isolates of methicillin-resistant 
Staphylococcus aureus (MRSA) have become the most common cause of infections among pathogenic 
bacteria around the Globe, and many life-threatening diseases such as endocarditis, pneumonia and 
toxin shock syndrome are ascribed to them. Contrary to methicillin-susceptible S. aureus (MSSA), 
MRSA tend to be multi-drug resistant (MDR), that is, resistant not only to β-lactam antibiotics but also 
to a wide range of different antibiotic classes, such as fluoroquinolones, tetracyclines, macrolides, 
lincosamides and aminoglycosides, and even strains of vancomycin intermediate susceptible or full 
resistant (VISA and VRSA, respectively) have emerged [1]. Therefore, the search for novel 
anti-MRSA agents is urgently needed. Meanwhile, great emphasis has been placed on the value of 
plants used in ethnomedicine and traditional medicine for drug discovery has currently been laid 
greater stress worldwide [2–5]. 
Traditional Chinese medicines (TCM), like Ayurveda, Unani and Kampo, have flourished as 
systems of medicine in use for thousands of years [2]. With more than 5,000 years of Chinese history 
and as a part of Chinese culture, TCM mainly used plant materials in organized traditional medical 
systems which have been playing a critical role in fighting various diseases and maintaing human 
health. Thousands of Chinese herbal medicines have been recorded in a great variety of national and 
local literatures such as Shen Nong’s Materia  Medica [6], Compendium of Materia Medica [7], 
Dictionary of Chinese Materia Medica [8],  Chinese Materia Medica [9], Compilation of Chinese 
Herbal Medicine [10] and Selected Yunnan Traditional Chinese Herbs [11] from ancient to modern 
times. They have been widely used throughout the country or in local areas by the Chinese people of  
all nationalities. 
In TCM clinical practice, the Chinese disease name “Chuang-Yang” (pyogenic infection and 
ulceration of skin) is a general terminology for the surgical and skin disease visible over the body surface 
and dermatosis, including “Yong Ju, Ding-Chuang, Jie-Zhong, Liu-Zhu, Liu-Tan,  etc.” (carbuncle, 
deep-seated sore, furuncle, multiple abscess, tuberculosis of bone and joint, scrofula, etc.). The diseases 
are commonly seen in clinic, due to stagnation of qi and blood stasized from the attack of evils and 
consumption of blood by heat-evil [12]. 
Many Chinese herbal medicines (or medicinal plants) have been documented as treatment of these 
diseases, which prompted us to investigate their inhibitory activity against MRSA. We herein report 
the in vitro anti-MRSA effects of a collection of 30 Chinese medicinal plants with reference to the 
treatment record of skin and other kinds of infections (Table 1). Molecules 2012, 17 2957 
 
 
Table 1. Traditional indications and phytohemical constitution of the 30 Chinese plants. 
No.  Species  Traditional Indication  Phytohemical Constitution 
1  A. nepalensis  bleeding of the nose, enteritis and dysentery 
tannins, triterpenoids, flavonoids, 
phenols 
2  B. balsamifer 
anti-rheumatism, ringworm and sores, dysentery, 
detoxification and snake bite 
flavonoids, simple terpenoids 
3  B. hancei 
heat clearing and detoxicating, dysentery, 
jaundice, boils, swelling, tuberculosis injury 
hematemesis, osteomyelitis, periostitis, 
rheumatism and pain 
hydroxytyrosol derivatives and 
glycosides 
4  C. austroglauca 
astringing sores, carbuncles, dysentery, 
hemostasis and vaginal discharge 
none 
5  C. japonica 
carbuncles, boils, mumps, erysipelas, 
rheumatism, jaundice, dysentery, hematuria and 
gonorrhea 
flavonoids (delphinidin 
glycosides) 
6  C. orbiculatus 
dysentery, multiple abscess, Herpes zoster, 
detoxification, inflammatory, cellulites and snake 
bite 
sesquiterpene, flavonoids 
7  C. orchioides  diarrhea, ulcer, pus and muscles atrophy 
triterpenoids, lignans, flavonoids, 
alkaloids, stereoids 
8  C. prainii  antipyresis, diuretic and chyluria 
alkaloids, polyphenols, 
flavonoids 
9  E. Burm 
heat clearing and detoxicating, pharyngitis, 
dysentery, diarrhea, furuncle ulcer, skin itching, 
swelling and pain of hemorrhoids, throat red and 
swollen, bleeding gums and traumatic injury. 
quinones, triterpenoids, 
flavonoids 
10  E. daneillii  diarrhea, abdominal pain and vomiting 
alkaloids, flavonoid glycosides, 
flavaprin, limonoids 
11  E. fortunei 
chronic diarrhea, dysentery, dispersing blood 
stasis and traumatic bleeding 
alkaloids, triterpenoids, 
flavonoids 
12  E. laxiflorus 
pesticide, rheumatism, bone fractures and 
hemoptysis 
alkaloids, triterpenoids, 
flavonoids, sesquiterpenes 
(agarofurans) 
13  G. morella 
wound rot, carbuncle, tinea, ulcer and sore, 
anthelminthic and containing toxic substances 
phenols (gambogic acid), 
flavonoids (xanthones), 
triterpenoids 
14  I. simonsii 
scabies, bladder hernias, mixed cropping of edible 
spices and containing toxic substances 
terpenoids, lignans, flavonoids, 
phenols 
15  K. angustifolia 
anti-infection, swelling and pain, ulcer and 
enteritis and heat stroke 
lignans, triterpenoids 
16  L. lancifolia  stomach pain, vomiting and swelling 
alkaloids, terpenoids, flavonoids, 
essential oils 
17  M. hongheensis 
vomiting, diarrhea, dysentery, constipation and 
geriatric hacking cough 
alkaloids 
18  M. salicina  carbuncle, furunculosis and sore pain  alkaloids, lignans Molecules 2012, 17 2958 
 
 
Table 1. Cont. 
No.  Species  Traditional Indication  Phytohemical Constitution 
19  M. squamulata 
scabies, carbuncle boils swollen poison, 
hemorrhoids, enterobiasis, beriberi, rheumatoid 
and snake bite 
triterpenoids 
20  M. yunnanensis 
hepatitis, sore, otitis media, stomach and 
duodenal ulcer, enlarged spleen and boils 
swelling, hematuria leucorrhea and traumatic 
bleeding 
Polyphenols,tannins，
flavonoids,coumarins, various 
terpenoids 
21  O. javanica 
lump in the abdomen, boils and swelling of throat 
and containing toxic substances 
falcarindiol, carotatoxin, 
5-allylpyrogallol 
22  P. edulis  (no record)  unsaturated organic acids 
23  P. molle  carbuncle, swollen abscess, fistula and scrofula  tannins, flavonoids, alkaloids 
24  R. japonicus 
subsiding swelling, jaundice, malaria lymph node 
tuberculosis and pterygium 
lactones (anemonin, 
protoanemonin), flavonoids 
25  S. arborescens 
HBV (skimmianine), rheumatoid, paralysisa, 
beriberi, and containing toxic substances 
alkaloids, coumarins, 
triterpenoids, phenols  
26  S. davidii 
antipyretic, detoxicate, subsiding swelling, 
laryngitis, pneumonia, dysentery, cystitis and edema
polyphenols 
27  S. parasitica  anti-rheumatism and anticancer  flavonoids 
28  S. sinensis  furuncle and swelling 
benzoquinone, tannins, phenols, 
lignans, flavonoids, triterpenoids 
29  S. tamariscina 
inflammation, pharyngolaryngitis and 
bacteriostasis 
flavonoids, phenol glycosides, 
trehalose 
30  S. viridis  urticaria, herpes zoster, rheumatism and analgesia lignans, triterpenoids, organic acids
2. Results and Discussion 
2.1. Results 
Table 1 shows the recorded TCM indications and phytohemical constitution of the 30 Chinese 
medicinal plants [6–11]. The antibacterial susceptible spectrum of the tested seven MRSA strains is 
listed in Table 2. The initial screening results of the 30 plant extracts against MSSA and other 
conventional standard strains of Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 
27853) and Candida albicans (ATCC Y0109) are expressed as inhibition zone diameters (IZDs) in 
Table 3, while anti-MRSA activities of the selected 21 extracts which were active with IZDs ≥10 mm 
against MSSA were shown in Table 4. Their corresponding MICs/MBCs (µg/mL) are shown in Table 5. 
Table 2. The antibacterial agent-susceptibility test results of MRSA strains. 
MRSA Strains  Resistant (R)  Intermediate (I)  Susceptible (S) 
MRSA 008 
PEN, OXS, AMP, LEV, CTX, PIP/S, ERY, CLI, 
AZM, RIF
NONE  VAN, TEC, LNZ, FOS, 
MRSA 082  AMP, CLI, RIF, CTX V, CIP, LEV, CAZ FOS LNZ,  VAN 
MRSA 092  AZM, OXS, AMP, FOX, CLI, CLR, LEV  NONE 
COT, RIF, PIP/S, VAN, 
GAT, FOS Molecules 2012, 17 2959 
 
 
Table 2. Cont. 
MRSA Strains  Resistant (R)  Intermediate (I)  Susceptible (S) 
MRSA 123  PEN, OXS, FOX, IPM CTS NONE  LNZ, VAN, MXF, FOS
MRSA 144 
PEN, AMP, OXS, FOX, FUR, CFZ, AZM, RIF, 
CLI, CLR 
NONE VAN,  FOS 
MRSA 189 
PEN, OXS, AMP, FOX, FUR, CTX, COT, CIP, 
LEV 
FOS VAN,  LNZ,  MXF 
MRSA 321 
CLR, CLI, AZM, PEN, OXS, AMP, ERY. CTX, 
FUR, LEV
CAT  VAN, GAT, PIP/T 
AMP: ampicillin; AZM: azithromycin; CAT: cefathiamidine; CAZ: ceftazidime; CFZ: cefazolin; 
CIP: ciprofloxacin; CLI: clindamycin; CLR: clarithromycin; COT: Cotrimoxazole; CTS: cilastatin 
sodium; CTX: Cefotaxime; ERY: erythromycin; FOS: fosfomycin; FOX: cefoxitin; FUR: cefuroxime; 
GAT: gatifloxacin; IPM: imipenem; LEV: levofloxacin; LNZ: linezolid; MXF: moxifloxacin;  
OXS: oxacillin; PEN: Penicillin; PIP: piperacillin; PIP/S: piperacillin/sulbactam; PIP/T: piperacillin/ 
tazobactam; RIF: rifampin; TEC: teicoplanin; VAN: Vancomycin. 
Table 3. Screening results of the antimicrobial activities of the extracts from 30 Chinese 
medicinal plants (IZD: mm) 
a.
 
No. Species  Part 
b Weight (g) 
c Ratio (%) 
d SA 
e EC 
f PA 
g CA 
h 
1  A. nepalensis  TBL 3.85  7.7  14  <8 12 9 
2  B. balsamifer  WP 0.61  1.2  12  9 <8  5 
3  B. hancei  WP 4.96  9.9  19  10  13  11 
4  C. austroglauca  TBL 1.50  3.0  23  14 15 9 
5  C. japonica  V 1.57  3.1  9  11  13  8 
6  C. orbiculatus  V 2.06  4.1  11  10  <8  10 
7  C. orchioides  WP 2.28  4.6  16  13  14  8 
8  C. prainii  WP 1.96  3.9  10  10  <8  9 
9  E. Burm  L 3.03  6.1  10  10  10  <8 
10  E. daneillii  TBL 2.52  5.0  18  12 10 9 
11  E. fortunei V  4.42  8.8  15  13  12  11 
12  E. laxiflorus TBL  2.68  5.4  <8  <8  <8  10 
13  G. morella WP  7.38  14.8 17  12  <8  <8 
14  I. simonsii  TBL 3.48  7.0  13  11 11 8 
15  K. angustifolia  TBL 0.99  2.0  <8  8  <8 8 
16  L. lancifolia  TBL  2.28 4.6 <8  <8  <8  <8 
17  M. hongheensis  TBL 3.09  6.2  21  11 13 <8 
18  M. salicina  TBL 2.91  5.8  12  9  8  10 
19  M. squamulata  TBL 1.48  2.9  17  12 12 11 
20  M. yunnanensis  TBL 2.91  5.8  24  12 <8 9 
21  O. javanica WP  2.65  5.3  <8  8  <8  <8 
22  P. edulis  TBL 4.49  9.0  <8  <8 <8 <8 
23  P. molle  WP 2.99  6.0  11  10  16  12 
24  R. japonicus  WP 5.24  10.5  <8  9 8 <8 
25  S. arborescens  TBL 1.86  3.7  24  13 14 11 
26  S. davidii  TBL 2.54  5.1  <8  8  9  10 
27  S. parasitica  TBL 1.04  2.1  <8  <8 <8 <8 Molecules 2012, 17 2960 
 
 
Table 3. Cont. 
No. Species  Part 
b Weight (g) 
c Ratio (%) 
d SA 
e EC 
f PA 
g CA 
h 
28  S. sinensis  TBL 6.49  13.0  18  8  13 21 
29  S. tamariscina  WP 4.44  8.9  12  9 11  9 
30  S. viridis  V 2.63  5.3  12  <8  <8  9 
a IZD: Inhibition zone diameter (the concentration of the extract at 50 mg/mL); 
b Part: The part of 
plant used for extraction (L: leaves; TBL: tender branches and leaves; WP: whole plant; V: vane);  
c Weight: The weight of extract; 
d Ratio: The ratio of extract; 
e SA: Staphylococcus aureus  
(ATCC 25923, MSSA); 
f EC: Escherichia coli (ATCC 25922); 
g PA: Pseudomonas aeruginosa 
(ATCC 27853); 
h CA: Candida albicans (ATCC Y0109). 
Table 4. Comparison of IZDs of the 21 extracts against MRSA and MSSA strains (IZD: mm) 
a. 
No. Extracts  MSSA  MRSAave ± SEM (n) 
b  △(MSSA-MRSAave) 
1  M. yunnanensis  24  17.5 ± 1.04 (4)  6.5 
2  S. arborescens  24  18.8 ± 2.06 (4)  5.2 
3  C. austroglauca  23  18.5 ± 1.85 (4)  4.5 
4  M. hongheensis  21  15.8 ± 1.65 (4)  5.2 
5  B. hancei  19  16.0 ± 1.63 (4)  3.0 
6  S. sinensis  18  14.3 ± 1.31 (4)  3.7 
7  E. daneillii  18  13.8 ± 1.31 (4)  4.2 
8  M. squamulata  17  14.5 ± 0.87 (4)  2.5 
9  G. morella  17  15.7 ± 0.67 (3)  1.3 
10  C. orchioides  16  17.3 ± 0.95 (4)  −1.3 
11  E. fortunei  15  15.5 ± 1.55 (4)  −0.5 
12  A. nepalensis  14  17.0 ± 1.41 (4)  −3.0 
13  I. simonsii  13  12.8 ± 1.11 (4)  0.2 
14  B. balsamifer  12  7.0 ± 1.22 (4)  5.0 
15  S. viridis  12  11.0 ± 1.68 (4)  1.0 
16  S. tamariscina  12  11.0 ± 1.00 (4)  1.0 
17  M. salicina  12  9.7 ± 0.33 (3)  2.3 
18  P. molle  11  15.8 ± 1.38 (4)  −4.8 
19  C. orbiculatus  11  9.5 ± 0.50 (4)  1.5 
20  E. Burm  10  13.0 ± 2.08 (3)  −3.0 
21  C. prainii  10  9.0 ± 1.00 (2)  1.0 
a IZD: Inhibition zone diameter (the concentration of the extract at 50 mg/mL); 
b Number of MRSA isolates. 
Table 5. Anti-MRSA activity of the extracts to the zone of inhibition against MSSA ≥10 mm 
(MIC/MBC: μg/mL). 
No. 
Extracts and 
Vancomycin 
Activity MSSA 
MRSA 
082
 
MRSA 
092
 
MRSA 
189
 
MRSA 
144
 
MRSA 
321
 
1  M. yunnanensis 
MIC  32  8  32 64 16 32 
MBC 128 64  256  128  64  256 
2  S. arborescens 
MIC  64  64  64 64 16 32 
MBC  256  256  256 256 128 128 
3  C. austroglauca 
MIC  64  64  64 64 32 16 
MBC  256  128  512 256 128 256 Molecules 2012, 17 2961 
 
 
Table 5. Cont. 
No. 
Extracts and 
Vancomycin 
Activity  MSSA 
MRSA 
082 
MRSA 
092 
MRSA 
189 
MRSA 
144 
MRSA 
321 
4  M. hongheensis 
MIC  32  128  8  32 16 16 
MBC  128  512  32 128  64 64 
5  B. hancei 
MIC  64  64  32 64 32 64 
MBC  128  256  256 128 128 256 
6  E. daneillii 
MIC  32  32  32 32 32 64 
MBC  64  256  128 256 256 256 
7  S. sinensis 
MIC  32  64  32 32 32 16 
MBC  128  256  256 64  128 64 
8  G. morella 
MIC  32  32  64 32 16 32 
MBC  256  256  256 128 64  128 
9  M. squamulata 
MIC  64  32  64 32 64 32 
MBC  256  128  256 128 256 128 
10  C. orchioides 
MIC  512  256  512 512 512 256 
MBC  1,024  1,024  >2,048 >2,048 512  1024 
11  E. fortunei 
MIC  512  512  512 512 512 512 
MBC  >2,048 >2,048  1,024  >2,048 >2,048 >2,048 
12  A. nepalensis 
MIC  1024  512  256 512 512 256 
MBC  >2,048 1,024  1,024  >2,048 >2,048 1,024 
13  I. simonsii 
MIC  512  512  512  1,024 1,024 1,024 
MBC  1,024  >2,048  >2,048 >2,048 >2,048 >2,048 
14  B. balsamifer 
MIC  256  256  256 64  256 128 
MBC  1,024  256  1,024 256  1,024 256 
15  M. salicina 
MIC  512  512  1,024  512 512 512 
MBC  1,024  >2,048  >2,048 >2,048 1,024  >2,048 
16  S. viridis 
MIC  256  128  64  128 128 128 
MBC  1,024  512  256 512 512 512 
17  S. tamariscina 
MIC  512  1,024  1,024 1,024 1,024 1,024 
MBC  1,024  >2,048  >2,048 2,048  >2,048 >2,048 
18  C. orbiculatus 
MIC  1,024  1,024  512 512 1,024  512 
MBC  >2,048 >2,048  1,024 1,024 >2,048  1,024 
19  P. molle 
MIC  512  256  256 256 256 256 
MBC  >2,048 1,024  1,024 1,024 1,024 1,024 
20  C. prainii 
MIC  1,024  1,024  1,024 1,024 1,024 2,048 
MBC  >2,048 >2,048  2,048  >2,048 >2,048 >2,048 
21  E. Burm 
MIC  512  512  1,024 1,024 1,024 1,024 
MBC  >2,048 1,024  >2,048 >2,048 >2,048 >2,048 
/ Vancomycin 
MIC  1  1  1 1 1 1 
MBC  2  2  2 2 2 2 
2.2. Discussion 
A collection of 30 Chinese medicinal plants were evaluated for their in vitro antimicrobial effects, 
especially their anti-MRSA potentials. Most of the plants with anti-infective effects related to skin Molecules 2012, 17 2962 
 
 
infections have been indicated in various works of Chinese herbal medicines either by themselves or 
the different species belonging to the same botanical genus, such as the indication of carbuncle which 
means a severe abscess or multiple boil in the skin, typically infected with S. bacteria (Table 1) [6–11]. 
The antimicrobial screening of all the plant species is being reported for the first time to the best of our 
knowledge, especially the anti-MRSA activities. 
The 80% ethanol extracts of the 30 Chinese medicinal plant extracts were initially subjected to the 
screening of their antimicrobial activities against MSSA and other conventional standard strains of 
Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853) and Candida albicans 
(ATCC Y0109). Their activities as IZDs (mm) at a concentration of 50 mg/mL ranged from <8 to 24, 
of which 21 extracts showed IZDs ≥10 mm against MSSA (Table 1). The results were in agreement 
with the literature record of traditional usages (Table 3) [6–11]. Judging from the IZD values, the 
extracts were generally more active against the Gram positive pathogen (MSSA) than against Gram 
negative (E. coli and P. aeruginosa) and fungal pathogens (C. albicans). The additional permeability 
barrier caused by the outer lipopolysaccharide layer in Gram negative bacteria makes them more 
resistant to plant natural products, as has been demonstrated previously [13,14]. Therefore, finding out 
anti-staphylococcal natural products from plant materials is much easier and is proved in the previous 
reports [15–18]. 
The tested MRSA strains were seven multi-drug resistant clinical isolates (Table 2). They were used 
for the further assay of their susceptibilities to the 21 extracts (Table 4). It is interesting that these 
extracts which were active against MSSA also showed more or less activity against MRSA with IZD 
values (mm) ranging between 9.0 and 18.8 and this has been noted previously [15–19]. The differences 
were from −3.0 to 6.5 mm in this study (Table 4). 
Anti-MRSA potency of MICs/MBCs (μg/mL) of the 21 extracts was determined as 8-2,048/32->2,048 
(Table 5). Comparison of the values of IZD and MIC for a same extract in Tables 4 and 5, they were 
not always positively correlated. As different sample concentrations will produce different IZDs, the 
real inhibitory potency of a sample should be judged by its MIC. This should be noted for future studies. 
From the phytochemical constitution of the 30 plant materials listed in Table 1, it is found that most 
of the active extracts contained tannins, (poly)phenols (including flavonoids, lignans and coumarins), 
terpenoids or alkaloids which have been reported [18,20–25]. 
The phytochemicals, including polyphenols and antimicrobial activity of Mallotus species have 
been reviewed [26,27]. Rottlerin from M. philippinensis exhibited potent bactericidal activity with an 
MBC value of 3.12–6.25 μg/mL against several clinical H. pylori isolates [28]. Garcinia genus is rich 
in caged xanthones [29]. Morellin isolated from gamboge (G. hanburyi, tenghuang in Chinese) was 
reported as an antibiotic principle in 1954 [30]. The anti-MRSA activity of morellin and other caged 
xanthones from Gamboge, G. morella and other Garcinia species have also reported [31,32]. Two 
antifungal compounds ulopterol (a coumarin) and a quinolone alkaloid 4-Methoxy-l-methyl-3- 
(2'-S-hydroxy-3'-ene-butyl)-2-quinolone were isolated from Skimmia laureola, a Pakistani medicinal 
plant [33], which were similar to our results of the inhibition of S. arborescens against C. albicans 
(Table 3). However, no active antimicrobial compounds from the other plant materials have been 
isolated up to now, especially the anti-MRSA compounds from the most active extracts of S. sinensis, 
E. daneillii, M. squamulata, and B. hancei, with MICs at 8–64 μg/mL. We are continuing our search for 
the corresponding phytochemicals from these plants and their further systematic anti-MRSA properties. Molecules 2012, 17 2963 
 
 
3. Experimental 
3.1. Plant Materials 
The selected 30 Chinese medicinal plant samples were collected from the tropical mountain forests of 
southeastern Yunnan Province of China, at altitudes of 1,500–3,074 m in June 2010. They were identiﬁed 
by Y.M. Shui at the Kunming Institute of Botany (KIB); the Chinese Academy of Sciences. Voucher 
specimens are preserved at the herbarium of KIB [34]. The names of species/family (specimen No.) 
were as the following: Alnus nepalensis D. Don./Betulaceae (KUN 35); Blumea balsamifer (Linn.) 
D.C./Asteraceae (KUN 21); Brandisia hancei Hook. f./Scrophulariaceae (YFS 6); Carex prainii C.B. 
Clarke/Cyperaceae (KUN 11133); Cayratiy japonica (Thunb) Gngacp.var.japonica/Vitaceae (YFS 531); 
Celastrus orbiculatus Thunb./Celastraceae (KUN 110); Curculigo orchioides Gaertn./Hypoxidaceae 
(KUN 1151); Cyclobalanopsis austroglauca Y.T. Chang/Fagaceae (SWFC 851222); Embelia Burm 
f./Myrsinaceae (KUN355); Euonymus  fortunei (Turcz.); Hand. Mazz./Celastraceae (YUKU (s.n)); 
Euonymus laxiflorus Charmp.ex.Benth./Celastraceae (YCP 851027); Evodia daneillii (Benn) 
Hemsl./Rutaceae (YFS 663); Garcinia morella Desr./Clusiaceae (YCP 851757); Illicium simonsii 
Maxim./Il1iciaceae (IBSC 125); Kadsura angustifolia A.C. Smith/Schisandraceae (KUN 4480); Litsea 
lancifolia (Roxb. ex. Nees); Benth. et. Hook. f. ex. F./Lauraceae (KUN 23); Machilus salicina 
Hance./Lauraceae (YUKU 1535); Mallotus yunnanensis Pax et. Hoffm./Euphorbiaceae (YFS 1144); 
Manglietia hongheensis Y.m Shui et. W.H. Chen./Magnoliaceae (KUN 262); Meliosma squamulata 
Hance./Lauraceae (KUN 2411); Oenanthe javanica (Bl.)DC./Umbellifera (KUN 214); Polygonum 
molle D. Don./Polygonaceae (KUN 367); Pyrularia edulis (Wall.) A.D.C./Santalaceae (KUN 60002100); 
Ranunculus japonicus Thumb./Ranunculaceae (KUN 2398); Schima sinensis (Hemsl. et. Wils) 
Airy-shaw./Theaceae (KUN158); Schisandra viridis A.c.Smith./Schisandraceae (YFS); Scurrula 
parasitica  Linn.var.  parasitica./Loranthaceae (YFS 327); Selaginella tamariscina (Seauv.) 
Spring./Selaginellaceae (YCP 85937); Skimmia arborescens Anders./Rutaceae (PE 100260); Sophora 
davidii (Franch.) Skeels./Leguminosae (YCP 851049). The traditional indications and phytochemical 
constitutions were listed in Table 1. 
3.2. Microbial Strains and Culture Media 
Standard bacterial and fungal strains, i.e.,  Staphylococcus aureus (ATCC 25923, MSSA), 
Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853) and Candida albicans 
(ATCC Y0109) were provided by the National Institute for the Control of Pharmaceutical and Biological 
Products (NICPBP, China). Clinical MDR MRSA strains of MRSA 8, MRSA 82, MRSA 92, MRSA 123, 
MRSA 144, MRSA 189 and MRSA 321 were clinical isolates from infectious samples of critically ill 
patients in Kunming General Hospital (KGH). Pathogen puriﬁcation and identiﬁcation (including 
colonial morphology, Gram staining and coagulase testing) were conducted in our clinical 
microbiology laboratory and further conﬁrmed by standard cefoxitin disk diffusion test following the 
Clinical and Laboratory Standards Institute (CLSI) guidelines [15,35,36]. ATCC 25923 was used as 
the control strain. Vancomycin (Eli Lilly Japan K.K., Seishin Laboratories) was used as a control 
anti-MRSA agent. Standard Mueller-Hinton agar and broth (MHA and MHB) and Sabouraud agar Molecules 2012, 17 2964 
 
 
(Tianhe Microbial Agents Co., Hangzhou, China) were used as the bacterial and fungal culture media, 
respectively. The antibacterial agents-susceptibility testing results of MRSA strains were shown in Table 2. 
3.3. Extract Preparation 
The 30 samples of the air-dried and ground plant materials (50 g) were macerated with 80% ethanol 
(500 mL) for 7 days, ﬁltered and the mare was further macerated twice with the same solvent 
overnight and ﬁltered after being sonicated for 30 min. The ﬁltrates were combined and the solvent 
was evaporated at 40 °C in vacuum to afford each of the plant extract (Table 3). 
3.4. Antimicrobial Screening 
The ethanol extracts of the 30 plants were primarily subjected to susceptibility screening against 
standard microbial strains according to the agar diffusion method on MHA (for the bacteria) or SA (for 
C. albicans) plates. The sample extracts (50 mg/mL in dimethyl sulfoxide) were pipetted into 6 mm (in 
diameter) holes punched in the agar of prepared agar plates, plating with inoculums of 1.5 × 10
8 CFU/mL 
for bacteria and 5 × 10
5 CFU/mL for C. albicans in advance, respectively and incubated at 35 °C  
(for C. albicans at 28 °C) for 24 h, measured and recorded the IZDs [15–17,37]. The solvent value was 
deducted accordingly to get ﬁnal results of activity. All experiments were carried out in triplicate. The 
test results were interpreted based on IZD as <10 mm for the resistance, =10 mm for the mildly susceptible, 
11–15 mm for moderately susceptible, ≥16 mm for the highly susceptible (Table 2). The 21 extracts 
with IZDs ≥10 mm against MSSA were further subjected to the assay of their IZDs against MRSA 
strains (Table 3). 
3.5. MICs and MBCs Assaying 
The extracts with IZDs ≥10 mm against MSSA were further subjected to the assay of their IZDs 
and minimal inhibitory concentrations and minimal bactericidal concentrations (MICs/MBCs) against 
MRSA strains by serial dilution method according to the procedures reported previously [15–17,38,39]. 
Briefly, MICs/MBCs were determined by the standardized broth (using MHB) microdilution 
techniques with starting inoculums of 5 × 10
5 CFU/mL for the bacteria according to CLSI (formally 
NCCLS) guidelines and incubated at 35 °C for 24 h. For the MBCs assaying, 0.1 mL aliquots from 
drug dilution wells with visual growth inhibition were plated onto MHA media. The lowest drug 
concentration that yielded three or fewer microorganism colonies was recorded as the MBC. They were 
determined in triplicate, with concentrations ranging up to 2048 μg/mL for all the extracts (Table 5). 
4. Conclusions 
The screening of in vitro antimicrobial activity of the ethanol extracts from 30 Chinese medicinal 
plants led to the confirmation of 21 extracts displaying both anti-MSSA and MRSA effects with 
various levels of potency which were in good agreement with their TCM indications of skin infections 
and modern phytochemical constituents, with M. yunnanensis and S. arborescens extracts being the 
most active against MRSA. The combination of TCM indications and phytochemical profiles is a 
promising approach to the search of anti-MRSA plant natural products. Molecules 2012, 17 2965 
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